» Articles » PMID: 35984545

Clinical and Therapeutic Aspects of Sideroblastic Anaemia with B-Cell Immunodeficiency, Periodic Fever and Developmental Delay (SIFD) Syndrome: a Systematic Review

Overview
Journal J Clin Immunol
Publisher Springer
Date 2022 Aug 19
PMID 35984545
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Sideroblastic anaemia with B-cell immunodeficiency, periodic fever and developmental delay (SIFD) syndrome is a novel rare autoinflammatory multisystem disorder. We performed a systematic review of the available clinical and therapeutics aspects of the SIFD syndrome.

Methods: A systematic review according to PRISMA approach, including all articles published before the 30 of July 2021 in Pubmed and EMBASE database, was performed.

Results: The search identified 29 publications describing 58 unique patients. To date, 41 unique mutations have been reported. Onset of disease is very early with a median age of 4 months (range 0-252 months). The most frequent manifestations are haematologic such as microcytic anaemia or sideroblastic anaemia (55/58), recurrent fever (52/58), neurologic abnormalities (48/58), immunologic abnormalities in particular a humoral immunodeficiency (48/58), gastrointestinal signs and symptoms (38/58), eye diseases as cataract and retinitis pigmentosa (27/58), failure to thrive (26/58), mucocutaneous involvement (29/58), sensorineural deafness (19/58) and others. To date, 19 patients (35.85%) died because of disease course (16) and complications of hematopoietic cell stems transplantation (3). The use of anti-TNFα and hematopoietic cell stems transplantation (HCST) is dramatically changing the natural history of this disease.

Conclusions: SIFD syndrome is a novel entity to consider in a child presenting with recurrent fever, anaemia, B-cell immunodeficiency and neurodevelopmental delay. To date, therapeutic guidelines are lacking but anti-TNFα treatment and/or HCST are attractive and might modify the clinical course of this syndrome.

Citing Articles

TRNT-1 Deficiency Is Associated with Loss of tRNA Integrity and Imbalance of Distinct Proteins.

Fatica T, Naas T, Liwak U, Slaa H, Souaid M, Frangione B Genes (Basel). 2023; 14(5).

PMID: 37239403 PMC: 10218503. DOI: 10.3390/genes14051043.


Case report: Muscle involvement in a Chinese patient with -related disorder.

Wei C, Liu Y, Yang Y, Wu Y, Liu J, Chang X Front Pediatr. 2023; 11:1160107.

PMID: 37215601 PMC: 10196124. DOI: 10.3389/fped.2023.1160107.


Spontaneous, simultaneous bilateral osteonecrosis of the femoral heads in a patient with sideroblastic anaemia with B-cell immunodeficiency, periodic fever and developmental delay syndrome.

Cai G, Jayaraman D BMJ Case Rep. 2023; 16(5).

PMID: 37130647 PMC: 10163426. DOI: 10.1136/bcr-2022-254175.


Case report: Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay: Three cases and a literature review.

Chen X, Fu F, Mo X, Cheng S, Zeng H Front Pediatr. 2023; 11:1001222.

PMID: 36937953 PMC: 10017860. DOI: 10.3389/fped.2023.1001222.

References
1.
Wedatilake Y, Niazi R, Fassone E, Powell C, Pearce S, Plagnol V . TRNT1 deficiency: clinical, biochemical and molecular genetic features. Orphanet J Rare Dis. 2016; 11(1):90. PMC: 4930608. DOI: 10.1186/s13023-016-0477-0. View

2.
Orlando F, Naddei R, Stellacci E, Gallinoro C, Melis D, Tartaglia M . Etanercept as a successful therapy in autoinflammatory syndrome related to TRNT1 mutations: a case-based review. Clin Rheumatol. 2021; 40(10):4341-4348. DOI: 10.1007/s10067-021-05653-3. View

3.
Hull S, Malik A, Arno G, Mackay D, Plagnol V, Michaelides M . Expanding the Phenotype of TRNT1-Related Immunodeficiency to Include Childhood Cataract and Inner Retinal Dysfunction. JAMA Ophthalmol. 2016; 134(9):1049-53. DOI: 10.1001/jamaophthalmol.2015.5833. View

4.
Barton C, Kausar S, Kerr D, Bitetti S, Wynn R . SIFD as a novel cause of severe fetal hydrops and neonatal anaemia with iron loading and marked extramedullary haemopoiesis. J Clin Pathol. 2017; 71(3):275-278. PMC: 5868532. DOI: 10.1136/jclinpath-2017-204698. View

5.
Fremond M, Melki I, Kracker S, Bondet V, Duffy D, Rice G . Comment on: 'Aberrant tRNA processing causes an autoinflammatory syndrome responsive to TNF inhibitors' by Giannelou : mutations in result in a constitutive activation of type I interferon signalling. Ann Rheum Dis. 2018; 78(8):e86. DOI: 10.1136/annrheumdis-2018-213745. View